Replies to post #21037 on RespireRx Pharmaceuticals Inc (RSPI)

[food4thought]

I thought the same thing. Don't you think cor management should have as well. Then again they had no idea the key stat man was going on a month long vacation. They should have tested lower doses in RD-2 to begin with or at least have tested the 2100mg cohort in the RD-1 trial. Then again what do I know, I just serve chicken and martinis for a living.